BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ira J Dunkel Julia C Chisholm Michela Casanova Andrea Ferrari |
| Publication date | January 19, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |